As reported by CheckMate-057 [24] and Keynote-010 [25], patients with high PD-L1 levels in tumor tissues, and who received PD-1/PD-L1 inhibitors, had better survival outcomes compared with those who were not given this treatment. Here, CD274 is linked to neoplasm.